<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03239418</url>
  </required_header>
  <id_info>
    <org_study_id>BRCRC2016_001</org_study_id>
    <nct_id>NCT03239418</nct_id>
  </id_info>
  <brief_title>NMES to Improve Eyelid Functions in Cranial Nerve (CN) III and VII Palsy</brief_title>
  <acronym>EyeStim</acronym>
  <official_title>A Novel Treatment Using Neuromuscular Electrical Stimulation to Improve Eyelid Function in Patients With CN III and CN VII Palsy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brooks Rehabilitation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brooks Rehabilitation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      Traumatic brain injury, stroke and other neurological conditions may result in weakness of
      the muscles that either open or close the eye. This is generally a result of impaired
      functioning of the oculomotor or facial cranial nerves. Current treatments to improve eye
      opening or closing are either invasive or largely ineffective. This study tests a noninvasive
      means of improving eyelid opening and closing by applying a previously demonstrated safe and
      effective neuromuscular electrical stimulation (NMES) intervention to the muscles controlling
      eyelid movement. Participants in this study will either receive the investigational NMES
      protocol 30 min per day for five days or a sham NMES for the same period. The primary outcome
      for this study is the participants' ability to open or close their affected eye. Secondary
      outcomes include additional measures of eye and corneal health.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 6, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Active treatment vs. Sham control</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Participants in treatment and sham group undergo all of the same procedures except a sham NMES treatment is provided to the control group. Only the treating clinician is aware of group allocation. The investigator and outcomes assessor are unaware of group allocation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Marginal reflex distance-1 (MRD-1)</measure>
    <time_frame>Within 1 week of last treatment session.</time_frame>
    <description>Measure of eyelid function for participants with CN III or CN VII palsy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Palpebral fissure height</measure>
    <time_frame>Within 1 week of last treatment session.</time_frame>
    <description>Measure of eyelid function for participants with CN III or CN VII palsy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>World Health Organization Quality of Life - BREF (WHOQOL-BREF)</measure>
    <time_frame>Within 1 week of last treatment session.</time_frame>
    <description>Measure of Quality of Life for participants with CN III or CN VII palsy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Upper eyelid crease distance</measure>
    <time_frame>Within 1 week of last treatment session.</time_frame>
    <description>Measure of eyelid function in participants with CN III or CN VII palsy</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Distance visual acuity</measure>
    <time_frame>Within 1 week of last treatment session.</time_frame>
    <description>Measure of overall eye health and function</description>
  </other_outcome>
  <other_outcome>
    <measure>Distance alternate cover test.</measure>
    <time_frame>Within 1 week of last treatment.</time_frame>
    <description>Measure of overall eye health and function</description>
  </other_outcome>
  <other_outcome>
    <measure>Pupil test</measure>
    <time_frame>Within 1 week of last treatment session.</time_frame>
    <description>Measure of overall eye health and function</description>
  </other_outcome>
  <other_outcome>
    <measure>Oculomotor exam</measure>
    <time_frame>Within 1 week of last treatment session.</time_frame>
    <description>Measure of overall eye health and function in participants with CN III palsy</description>
  </other_outcome>
  <other_outcome>
    <measure>Cornea, Static Asymmetry, Dynamic Function, Synkinesis Classification Scale (CADS).</measure>
    <time_frame>Within 1 week of last treatment session.</time_frame>
    <description>Measure of ophthalmic involvement in facial function in participants with CN VII palsy</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Blepharoptosis</condition>
  <condition>Lagophthalmos</condition>
  <arm_group>
    <arm_group_label>EyeStim Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receive an active NMES treatment to the targeted muscles controlling eyelid function.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Undergo all the same procedures as the EyeStim group except receive a sham NMES treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuromuscular electrical stimulation</intervention_name>
    <description>A low level electrical current is applied to the muscle that control eyelid function through small electrodes applied to the skin over the target muscles. Treatment is applied daily for 5 consecutive days and exercises for eyelid function are performed in conjunction with the stimulation.</description>
    <arm_group_label>EyeStim Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham neuromuscular electrical stimulation</intervention_name>
    <description>Electrodes are applied to the skin over the target muscles and patient perform the exercises for eyelid function for 5 consecutive days just as in the experimental group, However participants do not receive the electrical stimulation. Due to the low intensity of the stimulation all participants regardless of group allocation are told they may or may not feel the electrical stimulation.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cranial nerve III (oculomotor nerve) and/or cranial nerve IV (facial nerve) palsy.

          -  Able to read and communicate in English.

        Exclusion Criteria:

          -  Idiopathic onset of CN III and/or CN IV palsy.

          -  Traumatic injury to the eye or eyelid.

          -  Active wounds in the treatment area.

          -  Presence of swelling or infection in or surrounding the affected eye.

          -  Diminished sensation in the area to be treated.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth Ngo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brooks Rehabilitation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raine Osborne, DPT</last_name>
    <phone>904-345-6934</phone>
    <email>Raine.Osborne@Brooksrehab.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mallorey Smith</last_name>
    <phone>904-345-8970</phone>
    <email>Mallorey.Smith@Brooksrehab.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Brooks Rehabilitation</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raine Osborne, DPT</last_name>
      <phone>904-345-6934</phone>
      <email>Raine.Osborne@Brooksrehab.org</email>
    </contact>
    <contact_backup>
      <last_name>Mallorey Smith</last_name>
      <phone>904-345-870</phone>
      <email>Mallorey.Smith@Brooksrehab.org</email>
    </contact_backup>
    <investigator>
      <last_name>Kenneth Ngo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Connie Garces, DPT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katelyn Jorden, OD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sarah LaRosa, OT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lindsie Coleman, OT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raine Osborne, DPT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mallorey Smith</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2017</study_first_submitted>
  <study_first_submitted_qc>August 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2017</study_first_posted>
  <last_update_submitted>August 1, 2017</last_update_submitted>
  <last_update_submitted_qc>August 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NMES</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blepharoptosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

